Comment on Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan.
COVID-19
Japan
SARS-CoV-2
coronavirus
cost-effectiveness
vaccination
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
17 Oct 2024
17 Oct 2024
Historique:
received:
15
05
2024
revised:
04
10
2024
accepted:
11
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
26
10
2024
Statut:
epublish
Résumé
We noted three key inconsistencies in the Moderna-funded cost-effectiveness analysis by Fust et al [...].
Identifiants
pubmed: 39460340
pii: vaccines12101174
doi: 10.3390/vaccines12101174
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Pfizer (United States)
ID : n/a